An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 5, 2010, Pages 693-718

  Eisner, Mark D ^a   Anthonisen, Nicholas ^a   Coultas, David ^a   Kuenzli, Nino ^a   Perez Padilla, Rogelio ^a   Postma, Dirkje ^a   Romieu, Isabelle ^a   Silverman, Edwin K ^a   Balmes, John R ^a  

^a NONE

Author keywords

Air pollution; Asthma; Biomass; Chronic bronchitis; Chronic obstructive; Diet; Genetics; Indoor; Nutritional status; Occupational diseases; Occupational exposure; Pulmonary disease; Pulmonary emphysema; Respiratory function tests; Tobacco smoke pollution; Tuberculosis

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; FLAVONOID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

AIR POLLUTION; ASTHMA; CHRONIC BRONCHITIS; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIET; DISABILITY; DISEASE ASSOCIATION; EMPHYSEMA; FISH; FORCED EXPIRATORY VOLUME; FRUIT; HEALTH CARE POLICY; HEREDITY; LUNG FUNCTION; LUNG TUBERCULOSIS; MORTALITY; OCCUPATIONAL EXPOSURE; PASSIVE SMOKING; PHENOTYPE; POPULATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRAFFIC; VEGETABLE; AIR POLLUTANT; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; HUMAN; MEDICAL SOCIETY; SMOKING; UNITED STATES;

AIR POLLUTANTS; ASTHMA; DIET; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HEALTH POLICY; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SOCIETIES, MEDICAL; TOBACCO SMOKE POLLUTION; TUBERCULOSIS, PULMONARY; UNITED STATES;

EID: 77957719327     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200811-1757ST     Document Type: Review

References (303)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 2002;51:1-16.
2. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest 2003;123:1684-1692.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-1504.
4. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-398.
5. 1: the Lung Health Study. JAMA 1994;272:1497-1505.
6. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
7. U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006.
8. Committee on Gulf War and Health. Gulf war and health, Vol. 3: Fuels, combustion products, and propellants. Washington, DC: The National Academies Press; 2005.
9. U.S. Department of Health and Human Services. The health consequences of smoking: chronic obstructive lung disease. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health; 1984.
10. U.S. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
11. U.S. Department of Health, Education, and Welfare. Report of the advisory committee to the Surgeon General of the Public Health Service. Washington, DC: U.S. Department of Health, Education, and Welfare, Public Health Service, Communicable Disease Center; 1964.
12. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet 2003;362:847-852.
13. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 2000;53:755-761.
14. de Marco R, Accordini S, Cerveri I, Corsico A, Anto JM, Kunzli N, Janson C, Sunyer J, Jarvis D, Chinn S, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007;175:32-39.
15. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005;60:842-847. (Pubitemid 41475212)
16. Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, Uh ST, Shim JJ, Lew WJ. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 2005;172:842-847.
17. Kim SJ, Suk MH, Choi HM, Kimm KC, Jung KH, Lee SY, Lee SY, Kim JH, Shin C, Shim JJ, et al. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea. Int J Tuberc Lung Dis 2006;10:1393-1398.
18. Lindberg A, Bjerg A, Ronmark E, Larsson LG, Lundback B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006;100:264-272.
19. Lindberg A, Eriksson B, Larsson LG, Ronmark E, Sandstrom T, Lundback B. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 2006;129:879-885.
20. Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, Lundback B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration 2005;72:471-479.
21. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006;61:935-939.
22. Lundback B, Lindberg A, Lindstrom M, Ronmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandstrom T, Larsson K. Not 15 but 50% of smokers develop COPD?-report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003;97:115-122.
23. Malarcher AM, Schulman J, Epstein LA, Thun MJ, Mowery P, Pierce B, Escobedo L, Giovino GA. Methodological issues in estimating smoking-attributable mortality in the United States. Am J Epidemiol 2000;152:573-584.
24. Nihlen U, Nyberg P, Montnemery P, Lofdahl CG. Influence of family history and smoking habits on the incidence of self-reported physician's diagnosis of COPD. Respir Med 2004;98:263-270.
25. Sitas F, Urban M, Bradshaw D, Kielkowski D, Bah S, Peto R. Tobacco attributable deaths in South Africa. Tob Control 2004;13:396-399. (Pubitemid 39635927)
26. de Marco R, Accordini S, Cerveri I, Corsico A, Sunyer J, Neukirch F, Kunzli N, Leynaert B, Janson C, Gislason T, et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004;59:120-125.
27. Wilson D, Adams R, Appleton S, Ruffin R. Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study. Chest 2005;128:2035-2042.
28. Chan-Yeung M, Ho AS, Cheung AH, Liu RW, Yee WK, Sin KM, Wong MM, Lam CW, Chan KS, Lam WK. Determinants of chronic obstructive pulmonary disease in Chinese patients in Hong Kong. Int J Tuberc Lung Dis 2007;11:502-507.
29. Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, Katiyar SK, Kumar R, Shah B, Vijayan VK. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci 2006;48:23-29.
30. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003;114:758-762.
31. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-750.
32. Pelkonen M, Notkola IL, Nissinen A, Tukiainen H, Koskela H. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006;130:1129-1137. (Pubitemid 44583744)
33. Geijer RM, Sachs AP, Verheij TJ, Salome PL, Lammers JW, Hoes AW. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up. Br J Gen Pract 2006;56:656-661.
34. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007;176:753-760. (Pubitemid 47598476)
35. Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, Lundback B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005;127:1544-1552.
36. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO Study): a prevalence study. Lancet 2005;366:1875-1881.
37. Silverman EK. Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc 2006;3:405-408.
38. Man SF, Zamel N. Genetic influence on normal variability of maximum expiratory flow-volume curves. J Appl Physiol 1976;41:874-877.
39. Ghio AJ, Crapo RO, Elliott CG, Adams TD, Hunt SC, Jensen RL, Fisher AG, Afman GH. Heritability estimates of pulmonary function. Chest 1989;96:743-746.
40. Hubert HB, Fabsitz RR, Feinleib M, Gwinn C. Genetic and environmental influences on pulmonary function in adult twins. Am Rev Respir Dis 1982;125:409-415.
41. Redline S, Tishler PV, Lewitter FI, Tager IB, Munoz A, Speizer FE. Assessment of genetic and nongenetic influences on pulmonary function: a twin study. Am Rev Respir Dis 1987;135:217-222.
42. Devor EJ, Crawford MH. Family resemblance for normal pulmonary function. Ann Hum Biol 1984;11:439-448.
43. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly JJ, Ginns L, Mentzer S, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998;157:1770-1778.
44. McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ, Lomas DA. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001;164:1419-1424.
45. 25-75/FVC in families with severe, early onset COPD. Thorax 2004;59:396-400.
46. Postma DS, Meyers DA, Jongepier H, Howard TD, Koppelman GH, Bleecker ER. Genomewide screen for pulmonary function in 200 families ascertained for asthma. Am J Respir Crit Care Med 2005;172:446-452.
47. 1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978;204:345-351.
48. 1-Antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. Br J Dis Chest 1983;77:14-27.
49. 1-antitrypsin deficiency. Lancet 1985;1:152-154.
50. 1-Antitrypsin deficiency in nonsmokers. Am Rev Respir Dis 1978;117:421-428.
51. 1-antitrypsin deficiency with special reference to non-index cases. Thorax 1994;49:695-698. [Published errata appear in Thorax 1994;49:1184 and 1998;53:78.]
52. 1-antitrypsin deficiency (PiZZ). Thorax 1997;52:244-248.
53. 1-antitrypsin deficiency. Thorax 2007;62:806-813.
54. 1-antitrypsin deficiency. Am J Respir Cell Mol Biol 2008;38:114-120.
55. Rodriguez-Revenga L, Iranzo P, Badenas C, Puig S, Carrio A, Mila M. A novel elastin gene mutation resulting in an autosomal dominant form of cutis laxa. Arch Dermatol 2004;140:1135-1139.
56. Van Maldergem L, Vamos E, Liebaers I, Petit P, Vandevelde G, Simonis-Blumenfrucht A, Bouffioux R, Kulakowski S, Hanquinet S, Van Durme P, et al. Severe congenital cutis laxa with pulmonary emphysema: a family with three affected sibs. Am J Med Genet 1988;31:455-464.
57. Turner-Stokes L, Turton C, Pope FM, Green M. Emphysema and cutis laxa. Thorax 1983;38:790-792.
58. Wood JR, Bellamy D, Child AH, Citron KM. Pulmonary disease in patients with Marfan syndrome. Thorax 1984;39:780-784.
59. Dominguez R, Weisgrau RA, Santamaria M. Pulmonary hyperinflation and emphysema in infants with the Marfan syndrome. Pediatr Radiol 1987;17:365-369.
60. Dowton SB, Pincott S, Demmer L. Respiratory complications of Ehlers-Danlos syndrome type IV. Clin Genet 1996;50:510-514.
61. Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, Walther M, Choyke P, Weirich G, Hewitt SM, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev 2002;11:393-400.
62. Ayo DS, Aughenbaugh GL, Yi ES, Hand JL, Ryu JH. Cystic lung disease in Birt-Hogg-Dubé syndrome. Chest 2007;132:679-684.
63. Bense L, Eklund G, Lewander R. Hereditary pulmonary emphysema. Chest 2002;121:297-300.
64. Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2002;2:157-164.
65. Painter JN, Tapanainen H, Somer M, Tukiainen P, Aittomaki K. A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am J Hum Genet 2005;76:522-527.
66. DeMeo DL, Celedon JC, Lange C, Reilly JJ, Chapman HA, Sylvia JS, Speizer FE, Weiss ST, Silverman EK. Genome-wide linkage of forced mid-expiratory flow in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:1294-1301.
67. Hersh CP, Demeo DL, Lange C, Litonjua AA, Reilly JJ, Kwiatkowski D, Laird N, Sylvia JS, Sparrow D, Speizer FE, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005;33:71-78.
68. Wilk JB, Herbert A, Shoemaker CM, Gottlieb DJ, Karamohamed S. Secreted modular calcium-binding protein 2 haplotypes are associated with pulmonary function. Am J Respir Crit Care Med 2007;175:554-560.
69. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984;39:131-136.
70. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J 1999;14:892-896.
71. Cassino C, Berger KI, Goldring RM, Norman RG, Kammerman S, Ciotoli C, Reibman J. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med 2000;162:1423-1428.
72. Connolly CK, Chan NS, Prescott RJ. The relationship between age and duration of asthma and the presence of persistent obstruction in asthma. Postgrad Med J 1988;64:422-425.
73. Braman SS, Kaemmerlen JT, Davis SM. Asthma in the elderly: a comparison between patients with recently acquired and long-standing disease. Am Rev Respir Dis 1991;143:336-340.
74. Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, Chung KF. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004;24:122-128.
75. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001;164:744-748.
76. Vonk JM, Jongepier H, Panhuysen CI, Schouten JP, Bleecker ER, Postma DS. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax 2003;58:322-327.
77. Hudon C, Turcotte H, Laviolette M, Carrier G, Boulet LP. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction. Ann Allergy Asthma Immunol 1997;78:195-202.
78. Boulet LP, Turcotte H, Hudon C, Carrier G, Maltais F. Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD. Can Respir J 1998;5:270-277.
79. Vignola AM, Paganin F, Capieu L, Scichilone N, Bellia M, Maakel L, Bellia V, Godard P, Bousquet J, Chanez P. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J 2004;24:910-917.
80. Yilmaz S, Ekici A, Ekici M, Keles H. High-resolution computed tomography findings in elderly patients with asthma. Eur J Radiol 2006;59:238-243.
81. Kondoh Y, Taniguchi H, Yokoyama S, Taki F, Takagi K, Satake T. Emphysematous change in chronic asthma in relation to cigarette smoking: assessment by computed tomography. Chest 1990;97:845-849.
82. Paganin F, Seneterre E, Chanez P, Daures JP, Bruel JM, Michel FB, Bousquet J. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 1996;153:110-114.
83. Biernacki W, Redpath AT, Best JJ, MacNee W. Measurement of CT lung density in patients with chronic asthma. Eur Respir J 1997;10:2455-2459. (Pubitemid 28048615)
84. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200.
85. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-1648.
86. Fletcher C, Peto R, Tinker CM, Speizer FE. The natural history of chronic bronchitis and emphysema. London: Oxford University Press; 1976.
87. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-179.
88. Jaakkola MS, Jaakkola JJ, Ernst P, Becklake MR. Respiratory symptoms in young adults should not be overlooked. Am Rev Respir Dis 1993;147:359-366.
89. Almind M, Viskum K, Evald T, Dirksen A, Kok-Jensen A. A seven-year follow-up study of 343 adults with bronchial asthma. Dan Med Bull 1992;39:561-565.
90. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994;150:629-634.
91. Schachter EN, Doyle CA, Beck GJ. A prospective study of asthma in a rural community. Chest 1984;85:623-630.
92. Ulrik CS, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992;47:14-18.
93. Postma DS, Lebowitz MD. Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults. Arch Intern Med 1995;155:1393-1399.
94. Burrows B, Bloom JW, Traver GA, Cline MG. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987;317:1309-1314.
95. Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NH, Timens W, Postma DS. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006;61:105-110.
96. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, Musk AW. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005;171:109-114.
97. Gerritsen J, Koeter GH, Postma DS, Schouten JP, Knol K. Prognosis of asthma from childhood to adulthood. Am Rev Respir Dis 1989;140:1325-1330.
98. Panhuysen CI, Vonk JM, Koeter GH, Schouten JP, van Altena R, Bleecker ER, Postma DS. Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med 1997;155:1267-1272. [Published erratum appears in Am J Respir Crit Care Med 156:674.]
99. Van Schayck CP, Dompeling E, Van Herwaarden CL, Wever AM, Van Weel C. Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 1991;144:1297-1301.
100. van Schayck CP, Dompeling E, van Herwaarden CL, Folgering H, Verbeek AL, van der Hoogen HJ, van Weel C. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ 1991;303:1426-1431.
101. Lange P, Scharling H, Ulrik CS, Vestbo J. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006;61:100-104.
102. Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J 2007;30:452-456.
103. Gerritsen J, Koeter GH, de Monchy JG, Knol K. Allergy in subjects with asthma from childhood to adulthood. J Allergy Clin Immunol 1990;85:116-125.
104. Ostergaard PA. A prospective study on non-IgE-mediated asthma in children. Acta Paediatr Scand 1988;77:112-117.
105. 1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 2002;165:1480-1488.
106. Tennant PW, Gibson GJ, Pearce MS. Lifecourse predictors of adult respiratory function: results from the Newcastle Thousand Families Study. Thorax 2008;63:823-830.
107. Morgan WJ, Stern DA, Sherrill DL, Guerra S, Holberg CJ, Guilbert TW, Taussig LM, Wright AL, Martinez FD. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med 2005;172:1253-1258.
108. Kokkonen J, Linna O. The state of childhood asthma in young adulthood. Eur Respir J 1993;6:657-661.
109. Roorda RJ, Gerritsen J, van Aalderen WM, Schouten JP, Veltman JC, Weiss ST, Knol K. Follow-up of asthma from childhood to adulthood: influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol 1994;93:575-584.
110. Grol MH, Postma DS, Vonk JM, Schouten JP, Rijcken B, Koeter GH, Gerritsen J. Risk factors from childhood to adulthood for bronchial responsiveness at age 32-42 yr. Am J Respir Crit Care Med 1999;160:150-156.
111. Borsboom GJ, Van Pelt W, Quanjer PH. Pubertal growth curves of ventilatory function: relationship with childhood respiratory symptoms. Am Rev Respir Dis 1993;147:372-378.
112. Ulrik CS, Backer V, Dirksen A, Pedersen M, Koch C. Extrinsic and intrinsic asthma from childhood to adult age: a 10-yr follow-up. Respir Med 1995;89:547-554.
113. Kelly WJ, Hudson I, Phelan PD, Pain MC, Olinsky A. Childhood asthma in adult life: a further study at 28 years of age. Br Med J (Clin Res Ed) 1987;294:1059-1062.
114. Kelly WJ, Hudson I, Raven J, Phelan PD, Pain MC, Olinsky A. Childhood asthma and adult lung function. Am Rev Respir Dis 1988;138:26-30.
115. Weiss ST, Tosteson TD, Segal MR, Tager IB, Redline S, Speizer FE. Effects of asthma on pulmonary function in children: a longitudinal population-based study. Am Rev Respir Dis 1992;145:58-64.
116. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418-424.
117. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-1008.
118. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-743.
119. Sunyer J. Urban air pollution and chronic obstructive pulmonary disease: a review. Eur Respir J 2001;17:1024-1033.
120. Nicolai T, Carr D, Weiland SK, Duhme H, von Ehrenstein O, Wagner C, von Mutius E. Urban traffic and pollutant exposure related to respiratory outcomes and atopy in a large sample of children. Eur Respir J 2003;21:956-963.
121. Janssen NA, Brunekreef B, van Vliet P, Aarts F, Meliefste K, Harssema H, Fischer P. The relationship between air pollution from heavy traffic and allergic sensitization, bronchial hyperresponsiveness, and respiratory symptoms in Dutch schoolchildren. Environ Health Perspect 2003;111:1512-1518.
122. Hogervorst JG, de Kok TM, Briede JJ, Wesseling G, Kleinjans JC, van Schayck CP. Relationship between radical generation by urban ambient particulate matter and pulmonary function of school children. J Toxicol Environ Health A 2006;69:245-262.
123. Tager IB, Balmes J, Lurmann F, Ngo L, Alcorn S, Künzli N. Effect of chronic exposure to ambient ozone on lung function in young adults. Epidemiology 2005;16:751-759. (Pubitemid 41681541)
124. Holguin F, Flores S, Ross Z, Cortez M, Molina M, Molina L, Rincon C, Jerrett M, Berhane K, Granados A, et al. Traffic-related exposures, airway function, inflammation, and respiratory symptoms in children. Am J Respir Crit Care Med 2007;176:1236-1242.
125. Kulkarni N, Pierse N, Rushton L, Grigg J. Carbon in airway macrophages and lung function in children. N Engl J Med 2006;355:21-30.
126. Frye C, Hoelscher B, Cyrys J, Wjst M, Wichmann HE, Heinrich J. Association of lung function with declining ambient air pollution. Environ Health Perspect 2003;111:383-388.
127. Sugiri D, Ranft U, Schikowski T, Kramer U. The influence of large-scale airborne particle decline and traffic-related exposure on children's lung function. Environ Health Perspect 2006;114:282-288. (Pubitemid 43193653)
128. Peters JM, Avol E, Gauderman WJ, Linn WS, Navidi W, London SJ, Margolis H, Rappaport E, Vora H, Gong HJ, et al. A study of twelve Southern California communities with differing levels and types of air pollution. II. Effects on pulmonary function. Am J Respir Crit Care Med 1999;159:768-775. (Pubitemid 29137772)
129. Gauderman WJ, Avol E, Gilliland F, Vora H, Thomas D, Berhane K, McConnell R, Kuenzli N, Lurmann F, Rappaport E, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med 2004;351:1057-1067.
130. Gauderman WJ, Gilliland GF, Vora H, Avol E, Stram D, McConnell R, Thomas D, Lurmann F, Margolis HG, Rappaport EB, et al. Association between air pollution and lung function growth in Southern California children: results from a second cohort. Am J Respir Crit Care Med 2002;166:76-84.
131. Gauderman WJ, McConnell R, Gilliland F, London S, Thomas D, Avol E, Vora H, Berhane K, Rappaport EB, Lurmann F, et al. Association between air pollution and lung function growth in Southern California children. Am J Respir Crit Care Med 2000;162:1383-1390.
132. Gauderman WJ, Vora H, McConnell R, Berhane K, Gilliland F, Thomas D, Lurmann F, Avol E, Kunzli N, Jerrett M, et al. Effect of exposure to traffic on lung development from 10 to 18 years of age: a cohort study. Lancet 2007;369:571-577.
133. Avol EL, Gauderman WJ, Tan SM, London SJ, Peters JM. Respiratory effects of relocating to areas of differing air pollution levels. Am J Respir Crit Care Med 2001;164:2067-2072.
134. Rojas-Martinez R, Perez-Padilla R, Olaiz-Fernandez G, Mendoza-Alvarado L, Moreno-Macias H, Fortoul T, McDonnell W, Loomis D, Romieu I. Lung function growth in children with long-term exposure to air pollutants in Mexico City. Am J Respir Crit Care Med 2007;176:377-384.
135. Neuberger M, Moshammer H, Kundi M. Declining ambient air pollution and lung function improvement in Austrian children. Atmos Environ 2002;36:1733-1736.
136. Horak F Jr, Studnicka M, Gartner C, Spengler JD, Tauber E, Urbanek R, Veiter A, Frischer T. Particulate matter and lung function growth in children: a 3-yr follow-up study in Austrian schoolchildren. Eur Respir J 2002;19:838-845. (Pubitemid 34567896)
137. Ihorst G, Frischer T, Horak F, Schumacher M, Kopp M, Forster J, Mattes J, Kuehr J. Long- and medium-term ozone effects on lung growth including a broad spectrum of exposure. Eur Respir J 2004;23:292-299.
138. Frischer T, Studnicka M, Gartner C, Tauber E, Horak F, Veiter A, Spengler J, Kuhr J, Urbanek R. Lung function growth and ambient ozone: a three-year population study in school children. Am J Respir Crit Care Med 1999;160:390-396.
139. Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann HE, Kramer U. Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res 2005;6:152.
140. Ackermann-Liebrich U, Leuenberger P, Schwartz J, Schindler C, Monn C, Bolognini G, Bongard JP, Brandli O, Domenighetti G, Elsasser S, et al. Lung function and long term exposure to air pollutants in Switzerland: Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) team. Am J Respir Crit Care Med 1997;155:122-129.
141. Downs SH, Schindler C, Liu LJ, Keidel D, Bayer-Oglesby L, Brutsche MH, Gerbase MW, Keller R, Kunzli N, Leuenberger P, et al. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med 2007;357:2338-2347.
142. Kan H, Heiss G, Rose KM, Whitsel E, Lurmann F, London SJ. Traffic exposure and lung function in adults: the Atherosclerosis Risk in Communities Study. Thorax 2007;62:873-879.
143. Nakai S, Nitta H, Maeda K. Respiratory health associated with exposure to automobile exhaust. III. Results of a cross-sectional study in 1987, and repeated pulmonary function tests from 1987 to 1990. Arch Environ Health 1999;54:26-33.
144. Sekine K, Shima M, Nitta Y, Adachi M. Long term effects of exposure to automobile exhaust on the pulmonary function of female adults in Tokyo, Japan. Occup Environ Med 2004;61:350-357.
145. Euler G, Abbey D, Magie A, Hodgkin J. Chronic obstructive pulmonary disease symptom effects of long-term cumulative exposure to ambient levels of total suspended particulates and sulfur dioxide in California Seventh-day Adventist residents. Arch Environ Health 1987;42:213-222.
146. Abbey D, Burchette R, Knutsen S, McDonnel W, Lebowitz M, Enright P. Long-term particulate and other pollutants and lung function in nonsmokers. Am J Respir Crit Care Med 1998;158:289-298.
147. Karakatsani A, Andreadaki S, Katsouyanni K, Dimitroulis I, Trichopoulos D, Benetou V, Trichopoulou A. Air pollution in relation to manifestations of chronic pulmonary disease: a nested case-control study in Athens, Greece. Eur J Epidemiol 2003;18:45-53.
148. Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, Tran L, Stone V. The pulmonary toxicology of ultrafine particles. J Aerosol Med 2002;15:213-220.
149. Office of Environmental Health Hazard Assessment, California Environmental Protection Agency. Health effects assessment for environmental tobacco smoke. 2005.
150. Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health 2005;4:7.
151. Leuenberger P, Schwartz J, Ackermann-Liebrich U, Blaser K, Bolognini G, Bongard JP, Brandli O, Braun P, Bron C, Brutsche M, et al.; Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA team. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study) [see comments]. Am J Respir Crit Care Med 1994;150:1222-1228.
152. Simoni M, Baldacci S, Puntoni R, Pistelli F, Farchi S, Lo Presti E, Pistelli R, Corbo G, Agabiti N, Basso S, et al. Respiratory symptoms/diseases and environmental tobacco smoke (ETS) in never smoker Italian women. Respir Med 2007;101:531-538.
153. Robbins AS, Abbey DE, Lebowitz MD. Passive smoking and chronic respiratory disease symptoms in non-smoking adults. Int J Epidemiol 1993;22:809-817.
154. Iribarren C, Friedman GD, Klatsky AL, Eisner MD. Exposure to environmental tobacco smoke: association with personal characteristics and self
155. Jayet PY, Schindler C, Schwartz J, Kunzli N, Zellweger JP, Ackermann- Liebrich U, Leuenberger P. Passive smoking exposure among adults and the dynamics of respiratory symptoms in a prospective multicenter cohort study. Scand J Work Environ Health 2005;31:465-473.
156. Maziak W, Ward KD, Rastam S, Mzayek F, Eissenberg T. Extent of exposure to environmental tobacco smoke (ETS) and its dose-response relation to respiratory health among adults. Respir Res 2005;6:13.
157. Sezer H, Akkurt I, Guler N, Marakoglu K, Berk S. A case-control study on the effect of exposure to different substances on the development of COPD. Ann Epidemiol 2006;16:59-62.
158. Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, Zhang WS, Thomas GN, Adab P. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 2007;370:751-757.
159. Berglund DJ, Abbey DE, Lebowitz MD, Knutsen SF, McDonnell WF. Respiratory symptoms and pulmonary function in an elderly non-smoking population [see comments]. Chest 1999;115:49-59.
160. Dayal HH, Khuder S, Sharrar R, Trieff N. Passive smoking in obstructive respiratory disease in an industrialized urban population. Environ Res 1994;65:161-171.
161. Allwright S, Paul G, Greiner B, Mullally BJ, Pursell L, Kelly A, Bonner B, D'Eath M, McConnell B, McLaughlin JP, et al. Legislation for smoke-free workplaces and health of bar workers in Ireland: before and after study. BMJ 2005;331:1117.
162. Eisner MD, Smith AK, Blanc PD. Bartenders' respiratory health after establishment of smoke-free bars and taverns [see comments]. JAMA 1998;280:1909-1914.
163. Farrelly MC, Nonnemaker JM, Chou R, Hyland A, Peterson KK, Bauer UE. Changes in hospitality workers' exposure to secondhand smoke following the implementation of New York's smoke-free law. Tob Control 2005;14:236-241.
164. Goodman P, Agnew M, McCaffrey M, Paul G, Clancy L. Effects of the Irish smoking ban on respiratory health of bar workers and air quality in Dublin pubs. Am J Respir Crit Care Med 2007;175:840-845.
165. Hahn EJ, Rayens MK, York N, Okoli CT, Zhang M, Dignan M, Al-Delaimy WK. Effects of a smoke-free law on hair nicotine and respiratory symptoms of restaurant and bar workers. J Occup Environ Med 2006;48:906-913.
166. Menzies D, Nair A, Williamson PA, Schembri S, Al-Khairalla MZH, Barnes M, Fardon TC, McFarlane L, Magee GJ, Lipworth BJ. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA 2006;296:1742-1748.
167. Eagan TM, Hetland J, Aaro LE. Decline in respiratory symptoms in service workers five months after a public smoking ban. Tob Control 2006;15:242-246.
168. Dimich-Ward H, Lawason J, Chan-Yeung M. Work shift changes in lung function in bar workers exposed to environmental tobacco smoke [abstract]. Am J Respir Crit Care Med 1998;157:A505.
169. Ellingsen DG, Fladseth G, Daae HL, Gjolstad M, Kjaerheim K, Skogstad M, Olsen R, Thorud S, Molander P. Airborne exposure and biological monitoring of bar and restaurant workers before and after the introduction of a smoking ban. J Environ Monit 2006;8:362-368.
170. Skogstad M, Kjaerheim K, Fladseth G, Gjolstad M, Daae HL, Olsen R, Molander P, Ellingsen DG. Cross shift changes in lung function among bar and restaurant workers before and after implementation of a smoking ban. Occup Environ Med 2006;63:482-487.
171. Smith KR. Biofuels, air pollution, and health. New York: Plenum Press; 1987.
172. Anderson HR. Respiratory abnormalities and ventilatory capacity in a Papua New Guinea island community. Am Rev Respir Dis 1976;114:537-548.
173. Anderson HR. Chronic lung disease in the Papua New Guinea highlands. Thorax 1979;34:647-653.
174. Master KM. Air pollution in New Guinea: cause of chronic pulmonary disease among stone-age natives in the highlands. JAMA 1974;228:1653-1655.
175. Woolcock AJ, Blackburn CR. Chronic lung disease in the territory of Papua and New Guinea - an epidemiological study. Australas Ann Med 1967;16:11-19.
176. Woolcock AJ, Blackburn CR, Freeman MH, Zylstra W, Spring SR. Studies of chronic (nontuberculous) lung disease in New Guinea populations: the nature of the disease. Am Rev Respir Dis 1970;102:575-590.
177. Padmavati S, Arora R. Sex differences in chronic cor pulmonale in Delhi. Br J Dis Chest 1976;70:251-259.
178. Sandoval J, Salas J, Martinez-Guerra ML, Gomez A, Martinez C, Portales A, Palomar A, Villegas M, Barrios R. Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. Chest 1993;103:12-20.
179. Pandey M, Basnyat B, Neupane R. Chronic bronchitis and cor pulmonale in Nepal. Kathmandu: Mrigendra Medical Trust; 1988.
180. Ramirez-Venegas A, Sansores RH, Perez-Padilla R, Regalado J, Velazquez A, Sanchez C, Mayar ME. Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. Am J Respir Crit Care Med 2006;173:393-397. (Pubitemid 43228326)
181. Albalak R, Frisancho AR, Keeler GJ. Domestic biomass fuel combustion and chronic bronchitis in two rural Bolivian villages. Thorax 1999;54:1004-1008. (Pubitemid 29495395)
182. Behera D. An analysis of effect of common domestic fuels on respiratory function. Indian J Chest Dis Allied Sci 1997;39:235-243.
183. Behera D, Jindal SK. Respiratory symptoms in Indian women using domestic cooking fuels. Chest 1991;100:385-388.
184. Behera D, Jindal SK, Malhotra HS. Ventilatory function in nonsmoking rural Indian women using different cooking fuels. Respiration 1994;61:89-92.
185. Cetinkaya F, Gülmez I, Aydin T, Oztürk Y, Ozesmi M, Demir R. Prevalence of chronic bronchitis and associated risk factors in a rural area of Kayseri, central Anatolia, Turkey. Monaldi Arch Chest Dis 2000;55:189-193.
186. Dossing M, Khan J, al-Rabiah F. Risk factors for chronic obstructive lung disease in Saudi Arabia. Respir Med 1994;88:519-522.
187. Ekici A, Ekici M, Kurtipek E, Akin A, Arslan M, Kara T, Apaydin Z, Demir S. Obstructive airway diseases in women exposed to biomass smoke. Environ Res 2005;99:93-98. (Pubitemid 41046209)
188. Kiraz K, Kart L, Demir R, Oymak S, Gulmez I, Unalacak M, Ozesmi M. Chronic pulmonary disease in rural women exposed to biomass fumes. Clin Invest Med 2003;26:243-248.
189. Pandey MR. Domestic smoke pollution and chronic bronchitis in a rural-community of the hill region of Nepal. Thorax 1984;39:337-339.
190. Perez-Padilla R, Regalado J, Vedal S, Pare P, Chapela R, Sansores R, Selman M. Exposure to biomass smoke and chronic airway disease in Mexican women: a case-control study. Am J Respir Crit Care Med 1996;154:701-706.
191. Regalado J, Perez-Padilla R, Sansores R, Paramo Ramirez JI, Brauer M, Pare P, Vedal S. The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women. Am J Respir Crit Care Med 2006;174:901-905.
192. Shrestha IL, Shrestha SL. Indoor air pollution from biomass fuels and respiratory health of the exposed population in Nepalese households. Int J Occup Environ Health 2005;11:150-160.
193. Menezes AM, Victora CG, Rigatto M. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study. Thorax 1994;49:1217-1221.
194. Dutt D, Srinivasa DK, Rotti SB, Sahai A, Konar D. Effect of indoor air pollution on the respiratory system of women using different fuels for cooking in an urban slum of Pondicherry. Natl Med J India 1996;9:113-117. (Pubitemid 126477313)
195. Ellegard A. Cooking fuel smoke and respiratory symptoms among women in low-income areas in Maputo. Environ Health Perspect 1996;104:980-985.
196. Liu S, Zhou Y, Wang X, Wang D, Lu J, Zheng J, Zhong N, Ran P. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural south China. Thorax 2007;62:889-897.
197. Dennis RJ, Maldonado D, Norman S, Baena E, Martinez G. Wood-smoke exposure and risk for obstructive airways disease among women. Chest 1996;109:115-119. (Pubitemid 26017605)
198. Orozco-Levi M, Garcia-Aymerich J, Villar J, Ramirez-Sarmiento A, Anto JM, Gea J. Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur Respir J 2006;27:542-546. (Pubitemid 43372528)
199. Malik SK. Exposure to domestic cooking fuels and chronic bronchitis. Indian J Chest Dis Allied Sci 1985;27:171-174.
200. Akhtar T, Ullah Z, Khan MH, Nazli R. Chronic bronchitis in women using solid biomass fuel in rural Peshawar, Pakistan. Chest 2007;132:1472-1475. (Pubitemid 350156001)
201. Saha A, Rao NM, Kulkarni PK, Majumdar PK, Saiyed HN. Pulmonary function and fuel use: a population survey. Respir Res 2005;6:127.
202. Rinne ST, Rodas EJ, Bender BS, Rinne ML, Simpson JM, Galer-Unti R, Glickman LT. Relationship of pulmonary function among women and children to indoor air pollution from biomass use in rural Ecuador. Respir Med 2006;100:1208-1215.
203. Malik SK. Domestic cooking, chronic bronchitis and impairment of lung function in rural females. Indian J Chest Dis Allied Sci 1984;26:200-201.
204. Pandey MR, Regmi HN, Neupane RP, Gautam A, Bhandari DP. Domestic smoke pollution and respiratory function in rural Nepal. Tokai J Exp Clin Med 1985;10:471-481.
205. Caballero A, Torres-Duque CA, Jaramillo C, Bolivar F, Sanabria F, Osorio P, Orduz C, Guevara DP, Maldonado D. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL Study). Chest 2008;133:343-349.
206. Tesfaigzi Y, McDonald JD, Reed MD, Singh SP, De Sanctis GT, Eynott PR, Hahn FF, Campen MJ, Mauderly JL. Low-level subchronic exposure to wood smoke exacerbates inflammatory responses in allergic rats. Toxicol Sci 2005;88:505-513.
207. Lal K, Dutta KK, Vachhrajani KD, Gupta GS, Srivastava AK. Histomorphological changes in lung of rats following exposure to wood smoke. Indian J Exp Biol 1993;31:761-764.
208. Zhou X, Jin Y, He X. [A study on the relationship between in-door air pollution and chronic obstructive pulmonary disease in Xuanwei County]. Zhonghua Yu Fang Yi Xue Za Zhi 1995;29:38-40.
209. Chapman RS, He X, Blair AE, Lan Q. Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study. BMJ 2005;331:1050.
210. 1 in United States coal-miners. Thorax 1985;40:132-137.
211. Attfield MD, Hodous TK. Pulmonary function of U.S. coal miners related to dust exposure estimates. Am Rev Respir Dis 1992;145:605-609.
212. Seixas NS, Robins TG, Attfield MD, Moulton LH. Longitudinal and cross sectional analyses of exposure to coal mine dust and pulmonary function in new miners. Br J Ind Med 1993;50:929-937.
213. Love RG, Miller BG. Longitudinal study of lung function in coalminers. Thorax 1982;37:193-197. (Pubitemid 12154575)
214. Hnizdo E, Baskind E, Sluis-Cremer GK. Combined effect of silica dust exposure and tobacco smoking on the prevalence of respiratory impairments among gold miners. Scand J Work Environ Health 1990;16:411-422.
215. Holman CD, Psaila-Savona P, Roberts M, McNulty JC. Determinants of chronic bronchitis and lung dysfunction in Western Australian gold miners. Br J Ind Med 1987;44:810-818.
216. Ulvestad B, Bakke B, Eduard W, Kongerud J, Lund MB. Cumulative exposure to dust causes accelerated decline in lung function in tunnel workers. Occup Environ Med 2001;58:663-669. (Pubitemid 32881045)
217. Meijer E, Kromhout H, Heederik D. Respiratory effects of exposure to low levels of concrete dust containing crystalline silica. Am J Ind Med 2001;40:133-140. (Pubitemid 32738264)
218. Kauffmann F, Drouet D, Lellouch J, Brille D. Occupational exposure and 12-year spirometric changes among Paris area workers. Br J Ind Med 1982;39:221-232. (Pubitemid 12045484)
219. Becklake MR, Irwig L, Kielkowski D, Webster I, de Beer M, Landau S. The predictors of emphysema in South African gold miners. Am Rev Respir Dis 1987;135:1234-1241.
220. Cockcroft A, Seal RM, Wagner JC, Lyons JP, Ryder R, Andersson N. Post-mortem study of emphysema in coalworkers and non-coal-workers. Lancet 1982;2:600-603.
221. Leigh J, Driscoll TR, Cole BD, Beck RW, Hull BP, Yang J. Quantitative relation between emphysema and lung mineral content in coalworkers. Occup Environ Med 1994;51:400-407. (Pubitemid 24195246)
222. Ruckley VA, Fernie JM, Chapman JS, Collings P, Davis JM, Douglas AN, Lamb D, Seaton A. Comparison of radiographic appearances with associated pathology and lung dust content in a group of coalworkers. Br J Ind Med 1984;41:459-467.
223. Hnizdo E, Sluis-Cremer GK, Abramowitz JA. Emphysema type in relation to silica dust exposure in South African gold miners. Am Rev Respir Dis 1991;143:1241-1247.
224. Bakke P, Eide GE, Hanoa R, Gulsvik A. Occupational dust or gas exposure and prevalences of respiratory symptoms and asthma in a general population. Eur Respir J 1991;4:273-278.
225. Fishwick D, Bradshaw LM, D'Souza W, Town I, Armstrong R, Pearce N, Crane J. Chronic bronchitis, shortness of breath, and airway obstruction by occupation in New Zealand. Am J Respir Crit Care Med 1997;156:1440-1446. (Pubitemid 27505507)
226. 1 and airflow limitation related to occupational exposures in men of an urban community. Eur Respir J 1993;6:1095-1103.
227. Krzyzanowski M, Jedrychowski W. Occupational exposure and incidence of chronic respiratory symptoms among residents of Cracow followed for 13 years. Int Arch Occup Environ Health 1990;62:311-317.
228. Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study: risk of chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;134:1011-1019. (Pubitemid 17171663)
229. Lebowitz MD. Occupational exposures in relation to symptomatology and lung function in a community population. Environ Res 1977;14:59-67.
230. Post WK, Heederik D, Kromhout H, Kromhout D. Occupational exposures estimated by a population specific job exposure matrix and 25 year incidence rate of chronic nonspecific lung disease (CNSLD): the Zutphen Study. Eur Respir J 1994;7:1048-1055. (Pubitemid 24187323)
231. Viegi G, Prediletto R, Paoletti P, Carrozzi L, Di Pede F, Vellutini M, Di Pede C, Giuntini C, Lebowitz MD. Respiratory effects of occupational exposure in a general population sample in north italy. Am Rev Respir Dis 1991;143:510-515.
232. Xu X, Christiani DC, Dockery DW, Wang L. Exposure-response relationships between occupational exposures and chronic respiratory illness: a community-based study. Am Rev Respir Dis 1992;146:413-418.
233. Korn RJ, Dockery DW, Speizer FE, Ware JH, Ferris BG Jr. Occupational exposures and chronic respiratory symptoms: a population-based study. Am Rev Respir Dis 1987;136:298-304.
234. Krzyzanowski M, Kauffmann F. The relation of respiratory symptoms and ventilatory function to moderate occupational exposure in a general population: results from the French PAARC study of 16,000 adults. Int J Epidemiol 1988;17:397-406.
235. Sunyer J, Kogevinas M, Kromhout H, Anto JM, Roca J, Tobias A, Vermeulen R, Payo F, Maldonado JA, Martinez-Moratalla J, et al. Pulmonary ventilatory defects and occupational exposures in a population-based study in Spain: Spanish Group of the European Community Respiratory Health Survey. Am J Respir Crit Care Med 1998;157:512-517.
236. Weinmann S, Vollmer WM, Breen V, Heumann M, Hnizdo E, Villnave J, Doney B, Graziani M, McBurnie MA, Buist AS. COPD and occupational exposures: a case-control study. J Occup Environ Med 2008;50:561-569.
237. Boggia B, Farinaro E, Grieco L, Lucariello A, Carbone U. Burden of smoking and occupational exposure on etiology of chronic obstructive pulmonary disease in workers of southern Italy. J Occup Environ Med 2008;50:366-370.
238. Blanc PD, Iribarren C, Trupin L, Earnest G, Katz PP, Balmes J, Sidney S, Eisner MD. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax 2009;64:6-12.
239. Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003;167:787-797.
240. Jaen A, Zock JP, Kogevinas M, Ferrer A, Marin A. Occupation, smoking, and chronic obstructive respiratory disorders: a cross sectional study in an industrial area of Catalonia, Spain. Environ Health 2006;5:2.
241. Lange P, Parner J, Prescott E, Vestbo J. Chronic bronchitis in an elderly population. Age Ageing 2003;32:636-642.
242. LeVan TD, Koh WP, Lee HP, Koh D, Yu MC, London SJ. Vapor, dust, and smoke exposure in relation to adult-onset asthma and chronic respiratory symptoms: the Singapore Chinese Health Study. Am J Epidemiol 2006;163:1118-1128.
243. Matheson MC, Benke G, Raven J, Sim MR, Kromhout H, Vermeulen R, Johns DP, Walters EH, Abramson MJ. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax 2005;60:645-651.
244. Montnemery P, Bengtsson P, Elliot A, Lindholm LH, Nyberg P, Lofdahl CG. Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group. Respir Med 2001;95:744-752.
245. Suadicani P, Hein HO, Meyer HW, Gyntelberg F. Exposure to cold and draught, alcohol consumption, and the NS-phenotype are associated with chronic bronchitis: an epidemiological investigation of 3387 men aged 53-75 years: the Copenhagen Male Study. Occup Environ Med 2001;58:160-164.
246. Zock JP, Sunyer J, Kogevinas M, Kromhout H, Burney P, Anto JM. Occupation, chronic bronchitis, and lung function in young adults: an international study. Am J Respir Crit Care Med 2001;163:1572-1577.
247. de Meer G, Kerkhof M, Kromhout H, Schouten JP, Heederik D. Interaction of atopy and smoking on respiratory effects of occupational dust exposure: a general population-based study. Environ Health 2004;3:6.
248. Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, Katz PP, Blanc PD. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003;22:462-469.
249. Mak GK, Gould MK, Kuschner WG. Occupational inhalant exposure and respiratory disorders among never-smokers referred to a hospital pulmonary function laboratory. Am J Med Sci 2001;322:121-126.
250. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the us population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002;156:738-746. (Pubitemid 35155180)
251. Bergdahl IA, Toren K, Eriksson K, Hedlund U, Nilsson T, Flodin R, Jarvholm B. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J 2004;23:402-406.
252. Sunyer J, Zock JP, Kromhout H, Garcia-Esteban R, Radon K, Jarvis D, Toren K, Kunzli N, Norback D, d'Errico A, et al. Lung function decline, chronic bronchitis, and occupational exposures in young adults. Am J Respir Crit Care Med 2005;172:1139-1145.
253. Blanc PD, Toren K. Occupation in chronic obstructive pulmonary disease and chronic bronchitis: an update. Int J Tuberc Lung Dis 2007;11:251-257.
254. Cowie HA, Miller BG, Rawbone RG, Soutar CA. Dust related risks of clinically relevant lung functional deficits. Occup Environ Med 2006;63:320-325.
255. Hertzberg VS, Rosenman KD, Reilly MJ, Rice CH. Effect of occupational silica exposure on pulmonary function. Chest 2002;122:721-728.
256. Hu Y, Chen B, Yin Z, Jia L, Zhou Y, Jin T. Increased risk of chronic obstructive pulmonary diseases in coke oven workers: interaction between occupational exposure and smoking. Thorax 2006;61:290-295.
257. Lamprecht B, Schirnhofer L, Kaiser B, Studnicka M, Buist AS. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study. Am J Ind Med 2007;50:421-426.
258. Monso E, Magarolas R, Radon K, Danuser B, Iversen M, Weber C, Opravil U, Donham KJ, Nowak D. Respiratory symptoms of obstructive lung disease in European crop farmers. Am J Respir Crit Care Med 2000;162:1246-1250.
259. Wang ML, Wu ZE, Du QG, Petsonk EL, Peng KL, Li YD, Li SK, Han GH, Atffield MD. A prospective cohort study among new Chinese coal miners: the early pattern of lung function change. Occup Environ Med 2005;62:800-805.
260. Shore S, Kobzik L, Long NC, Skornik W, Van Staden CJ, Boulet L, Rodger IW, Pon DJ. Increased airway responsiveness to inhaled methacholine in a rat model of chronic bronchitis. Am J Respir Crit Care Med 1995;151:1931-1938.
261. Churg A, Hobson J, Wright J. Functional and morphologic comparison of silica- and elastase-induced airflow obstruction. Exp Lung Res 1989;15:813-822.
262. Bonner JC, Rice AB, Moomaw CR, Morgan DL. Airway fibrosis in rats induced by vanadium pentoxide. Am J Physiol Lung Cell Mol Physiol 2000;278:L209-L216.
263. Harkema JR, Hotchkiss JA. Ozone- and endotoxin-induced mucous cell metaplasias in rat airway epithelium: novel animal models to study toxicant-induced epithelial transformation in airways. Toxicol Lett 1993;68:251-263. (Pubitemid 23180227)
264. Shapiro SD. Animal models for COPD. Chest 2000;117:223S-227S.
265. 1-antitrypsin deficiency. Am J Respir Crit Care Med 2000;162:553-558.
266. Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 2001;23:268-287.
267. McKeever TM, Scrivener S, Broadfield E, Jones Z, Britton J, Lewis SA. Prospective study of diet and decline in lung function in a general population. Am J Respir Crit Care Med 2002;165:1299-1303.
268. Schunemann HJ, McCann S, Grant BJ, Trevisan M, Muti P, Freudenheim JL. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol 2002;155:463-471.
269. Schunemann HJ, Grant BJ, Freudenheim JL, Muti P, Browne RW, Drake JA, Klocke RA, Trevisan M. The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med 2001;163:1246-1255.
270. Schunemann HJ, Freudenheim JL, Grant BJR. Epidemiologic evidence linking antioxidant vitamins to pulmonary function and airway obstruction. Epidemiol Rev 2001;23:248-267.
271. Chuwers P, Barnhart S, Blanc P, Brodkin CA, Cullen M, Kelly T, Keogh J, Omenn G, Williams J, Balmes JR. The protective effect of β-carotene and retinol on ventilatory function in an asbestos-exposed cohort. Am J Respir Crit Care Med 1997;155:1066-1071.
272. Guenegou A, Leynaert B, Pin I, Le Moel G, Zureik M, Neukirch F. Serum carotenoids, vitamins A and E, and 8 year lung function decline in a general population. Thorax 2006;61:320-326.
273. Kelly Y, Sacker A, Marmot M. Nutrition and respiratory health in adults: findings from the Health Survey for Scotland. Eur Respir J 2003;21:664-671. (Pubitemid 36432523)
274. Carey IM, Strachan DP, Cook DG. Effects of changes in fresh fruit consumption on ventilatory function in healthy British adults. Am J Respir Crit Care Med 1998;158:728-733.
275. Miedema I, Feskens EJ, Heederik D, Kromhout D. Dietary determinants of long-term incidence of chronic nonspecific lung diseases: the Zutphen Study. Am J Epidemiol 1993;138:37-45.
276. Rautalahti M, Virtamo J, Haukka J, Heinonen OP, Sundvall J, Albanes D, Huttunen JK. The effect of α-tocopherol and β-carotene supplementation on COPD symptoms. Am J Respir Crit Care Med 1997;156:1447-1452.
277. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:23-33.
278. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey. Chest 2005;128:3792-3798.
279. Ricciardolo FL, Di Stefano A, Sabatini F, Folkerts G. Reactive nitrogen species in the respiratory tract. Eur J Pharmacol 2006;533:240-252.
280. Jiang R, Paik DC, Hankinson JL, Barr RG. Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults. Am J Respir Crit Care Med 2007;175:798-804.
281. Jiang R, Camargo CA Jr, Varraso R, Paik DC, Willett WC, Barr RG. Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women. Am J Clin Nutr 2008;87:1002-1008.
282. Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE, Willett WC. A prospective study of intake of vitamins C, E and A and risk of breast cancer. N Engl J Med 1993;329:234-240. (Pubitemid 23203814)
283. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000;55:32-38.
284. Menezes AMB, Hallal PC, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Pertuze J, et al. Tuberculosis and airflow obstruction: evidence from a multicentre survey in Latin America. Eur Respir J 2007;30:1-6.
285. Lowe CR. An association between smoking and respiratory tuberculosis. BMJ 1956;2:1081-1086.
286. Mishra VK, Retherford RD, Smith KR. Biomass cooking fuels and prevalence of tuberculosis in India. Int J Infect Dis 1999;3:119-129.
287. Perez-Padilla R, Perez-Guzman C, Baez-Saldana R, Torres-Cruz A. Cooking with biomass stoves and tuberculosis: a case control study. Int J Tuberc Lung Dis 2001;5:441-447.
288. Higgins M, Keller J. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity. J Chronic Dis 1975;28:239-251.
289. Tager IB, Rosner B, Tishler PV, Speizer FE, Kass EH. Household aggregation of pulmonary function and chronic bronchitis. Am Rev Respir Dis 1976;114:485-492.
290. Lewitter FI, Tager IB, McGue M, Tishler PV, Speizer FE. Genetic and environmental determinants of level of pulmonary function. Am J Epidemiol 1984;120:518-529.
291. Lebowitz MD, Knudson RJ, Burrows B. Family aggregation of pulmonary function measurements. Am Rev Respir Dis 1984;129:8-11.
292. Astemborski JA, Beaty TH, Cohen BH. Variance components analysis of forced expiration in families. Am J Med Genet 1985;21:741-753.
293. Palmer LJ, Knuiman MW, Divitini ML, Burton PR, James AL, Bartholomew HC, Ryan G, Musk AW. Familial aggregation and heritability of adult lung function: results from the Busselton Health Study. Eur Respir J 2001;17:696-702.
294. Gotschi T. Long term effects of air pollution on lung function in the European Community Respiratory Health Survey. Doctoral thesis. Department of Preventive Medicine, University of Southern California USC Keck School of Medicine. Los Angeles: University of Southern California USC Keck School of Medicine; 2007. p. 172.
295. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol 2000;151:975-981.
296. Butland BK, Fehily AM, Elwood PC. Diet, lung function, and lung function decline in a cohort of 2512 middle aged men. Thorax 2000;55:102-108.
297. Sharp DS, Rodriguez BL, Shahar E, Hwang LJ, Burchfiel CM. Fish consumption may limit the damage of smoking on the lung. Am J Respir Crit Care Med 1994;150:983-987.
298. Grievink L, Smit HA, Ocké MC, van't Veer P, Kromhout D. Dietary intake of antioxidant (pro)-vitamins, respiratory symptoms and pulmonary function: the MORGEN Study. Thorax 1998;53:166-171.
299. Chen R, Tunstall-Pedoe H, Bolton-Smith C, Hannah MK, Morrison C. Association of dietary antioxidants and waist circumference with pulmonary function and airway obstruction. Am J Epidemiol 2001;153:157-163.
300. Tabak C, Smit HA, Heederik D, Ocke MC, Kromhout D. Diet and chronic obstructive pulmonary disease: independent beneficial effects of fruits, whole grains, and alcohol (the MORGEN Study). Clin Exp Allergy 2001;31:747-755.
301. Shahar E, Folsom AR, Melnick SL, Tockman MS, Comstock GW, Gennaro V, Higgins MW, Sorlie PD, Ko WJ, Szklo M, et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Engl J Med 1994;331:228-233.
302. Tabak C, Feskens E. Heederik D, Kromhout D, Menotti A, Blackburn HW; for Seven Countries Study Group. Fruit and fish consumption: a possible explanation for population differences in COPD mortality (the Seven Countries Study). Eur J Clin Nutr 1998;52:819-825.
303. McKeever TM, Lewis SA, Cassano PA, Ocké M, Burney P, Britton J, Smit HA. The relation between dietary intake of individual fatty acids, FEV1 and respiratory disease in Dutch adults. Thorax 2008;63:208-214.